GANX Price Target Alert: $10.00. Issued by Roth Capital

December 19, 2025 02:05:58 pm

Source: KlickAnalytics

2025-12-19 14:05:58 ET

from Roth Capital issued a price target of $10.00 for GANX on 2025-12-19 18:34:21.

The adjusted price target was set to $10.00.

At the time of the announcement, GANX was trading at $2.7859.

The overall price target consensus is at $7.50 with high price of $8.00, low price of $7.00, and median price is at $7.50.

Gain Therapeutics Inc.

0.51% G/L:

$1.985 Last:

237,985 Volume:

$1.95 Open:

March 26, 2026 07:00:00 am

March 19, 2026 04:57:09 pm

March 18, 2026 08:15:00 am

March 12, 2026 07:00:00 am

Market Cap $88,106,499

Float 46,203,645

Insiders Ownership 0.36%

Institutions 12

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Bethesda